Clinical Trial Update: Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control [Phase 4]

View source ↗

Summary

Update on a Phase 4 trial evaluating linagliptin in combination with metformin for treatment-naive patients with Type 2 diabetes mellitus and insufficient glyce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)
• metformin (metformin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2014-06-03